This product is for research use only, not for human use. We do not sell to patients.
Size | Price | Stock |
---|---|---|
100mg | $750 | Check With Us |
250mg | $1300 | Check With Us |
500mg | $1950 | Check With Us |
Cat #: V37599 CAS #: 2289690-31-7 Purity ≥ 99%
Description: MYCi361 (NUCC0196361) is a novel and potent MYC inhibitor (Kd = 3.2 μM) with potential anticancer activity, it demonstrated a narrow therapeutic index. MYCi361 engaged MYC inside cells, disrupted MYC/MAX dimers, and impaired MYC-driven gene expression.
Publications Citing InvivoChem Products
Product Promise
- Physicochemical and Storage Information
- Protocol
- Related Biological Data
- Stock Solution Preparation
- Quality Control Documentation
Molecular Weight (MW) | 594.86 |
---|---|
Molecular Formula | C26H16ClF9N2O2 |
CAS No. | 2289690-31-7 |
Protocol | In Vitro | MYCi361 inhibits the viability of MYC-dependent cancer cells including prostate cancer (MycCaP, LNCaP, and PC3), leukemia (MV4-11), lymphoma (HL-60 and P493-6), and neuroblastoma (SK-N-B2) with low-micromolar IC50 values |
---|---|---|
In Vivo | MYCi361 inhibits MYC-dependent tumor growth in vivo. MYCi361 treatment (100 mg/kg/day for 2 days; then 70 mg/kg/day for 9 days) induces tumor regression in FVB or NSG male mice |
Solvent volume to be added | Mass (the weight of a compound) | |||
---|---|---|---|---|
Mother liquor concentration | 1mg | 5mg | 10mg | 20mg |
1mM | 1.6811 mL | 8.4053 mL | 16.8107 mL | 33.6214 mL |
5mM | 0.3362 mL | 1.6811 mL | 3.3621 mL | 6.7243 mL |
10mM | 0.1681 mL | 0.8405 mL | 1.6811 mL | 3.3621 mL |
20mM | 0.0841 mL | 0.4203 mL | 0.8405 mL | 1.6811 mL |
This equation is commonly abbreviated as: C1 V1 = C2 V2
- (1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
- (2) Be sure to add the solvent(s) in order.